75 related articles for article (PubMed ID: 7060016)
1. Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids.
Galili U; Leizerowitz R; Moreb J; Gamliel H; Gurfel D; Polliack A
Cancer Res; 1982 Apr; 42(4):1433-40. PubMed ID: 7060016
[TBL] [Abstract][Full Text] [Related]
2. Sequential irreversible, actinomycin D-sensitive, and cycloheximide-sensitive steps prior to cortisol inhibition of uridine utilization by P1798 tumor lymphocytes.
Stevens J; Stevens YW
Cancer Res; 1975 Aug; 35(8):2145-53. PubMed ID: 1149029
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid induced cytolysis of human normal and malignant lymphocytes.
Galili U
J Steroid Biochem; 1983 Jul; 19(1B):483-90. PubMed ID: 6577245
[TBL] [Abstract][Full Text] [Related]
4. Be13, a human T-leukemia cell line highly sensitive to dexamethasone-induced cytolysis.
Galili U; Peleg A; Milner Y; Galili N
Cancer Res; 1984 Oct; 44(10):4594-601. PubMed ID: 6331881
[TBL] [Abstract][Full Text] [Related]
5. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
6. Effects and receptors of glucocorticoids in rat thymus cells and human peripheral lymphocytes.
Munck A; Crabtree GR; Smith KA
J Toxicol Environ Health; 1978; 4(2-3):409-25. PubMed ID: 351204
[TBL] [Abstract][Full Text] [Related]
7. In vitro sensitivity to steroid hormones and cytotoxic agents of normal and malignant lymphocyte colony-forming cells.
Taetle R; To D; Mendelsohn J
Cancer Res; 1983 Aug; 43(8):3553-8. PubMed ID: 6602652
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural aspects of colchicine ultrasensitivity in CLL lymphocytes.
Allen TD; Scarffe JH; Crowther D
Blood Cells; 1981; 7(1):147-60. PubMed ID: 6892345
[TBL] [Abstract][Full Text] [Related]
9. Morphological aspects of glucocorticoid-induced cell death in human lymphoblastoid cells.
Robertson AM; Bird CC; Waddell AW; Currie AR
J Pathol; 1978 Nov; 126(3):181-7. PubMed ID: 745025
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucocorticoids on Fas gene expression in bovine blood neutrophils.
Chang LC; Madsen SA; Toelboell T; Weber PS; Burton JL
J Endocrinol; 2004 Dec; 183(3):569-83. PubMed ID: 15590983
[TBL] [Abstract][Full Text] [Related]
11. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression.
Dovio A; Sartori ML; Masera RG; Racca S; Angeli A
Cytokine; 2001 Jul; 15(1):47-52. PubMed ID: 11509008
[TBL] [Abstract][Full Text] [Related]
13. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
[TBL] [Abstract][Full Text] [Related]
14. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia.
Shahidi H; Vottero A; Stratakis CA; Taymans SE; Karl M; Longui CA; Chrousos GP; Daughaday WH; Gregory SA; Plate JM
Biochem Biophys Res Commun; 1999 Jan; 254(3):559-65. PubMed ID: 9920778
[TBL] [Abstract][Full Text] [Related]
15. Detection of glucocorticoid receptors in cultured human trabecular cells.
Weinreb RN; Bloom E; Baxter JD; Alvarado J; Lan N; O'Donnell J; Polansky JR
Invest Ophthalmol Vis Sci; 1981 Sep; 21(3):403-7. PubMed ID: 7275526
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid effects on HeLa S3 cell growth and thymidine incorporation.
Cidlowski JA; Cidlowski NB
Cancer Res; 1981 Jul; 41(7):2687-91. PubMed ID: 7248937
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of the in vitro responses to glucocorticoids in acute leukemia.
Homo F; Duval D; Harousseau JL; Marie JP; Zittoun R
Cancer Res; 1980 Jul; 40(7):2601-8. PubMed ID: 6930326
[TBL] [Abstract][Full Text] [Related]
19. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of human T-cells: induction by glucocorticoids or surface receptor ligation in vitro and ex vivo.
Kirsch AH; Mahmood AA; Endres J; Bohra L; Bonish B; Weber K; Fox DA
J Biol Regul Homeost Agents; 1999; 13(2):80-9. PubMed ID: 10503730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
